Brentuximab Vedotin [brentuximab vedotin]

topical
40
Terms

Adcetris
cAC10-vcMMAE
SGN-35

 

Adcetris
CAC10-1006
cAC10-vcMMAE
SGN-35

Definition

Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.

DUI
D000079963 MeSH Browser
CUI
M0551563
History note
2020 (2010)
Public note
2020; BRENTUXIMAB VEDOTIN was indexed under IMMUNOCONJUGATES 2010-2019

D Chemicals and Drugs
D12.644 Peptides 1 380
D12.644.456 Oligopeptides 324
D12.644.456.050 Amanitins 30
D12.644.456.073 Angiotensins 181
D12.644.456.120 Antipain
D12.644.456.157 Atazanavir Sulfate 5
D12.644.456.193 Bradykinin 100
D12.644.456.217 Brentuximab Vedotin 40
D12.644.456.241 Ceruletide 10
D12.644.456.270 Chalones 13
D12.644.456.345 Dipeptides 143
D12.644.456.448 Glutathione 534
D12.644.456.580 Leupeptins 11
D12.644.456.650 Netropsin 4
D12.644.456.716 Pentagastrin 23
D12.644.456.724 Pepstatins 9
D12.644.456.726 Peptichemio
D12.644.456.729 Peptide T
D12.644.456.735 Phalloidine 17
D12.644.456.800 Tachykinins 9
D12.644.456.810 Teprotide
D12.644.456.830 Tetragastrin
D12.644.456.840 Tuftsin 5
D12.644.456.925 Vasopressins 510
D12.776 Proteins 2 575
D12.776.124 Blood Proteins 909
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 486
D12.776.124.486.485.114 Antibodies 1 815
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 626
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 783
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 346
D12.776.124.486.485.114.224.060.313 Alemtuzumab 123
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 445
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 40
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 47
D12.776.124.486.485.114.224.060.750 Cetuximab 185
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 150
D12.776.124.486.485.114.224.060.790 Gemtuzumab 16
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 11
D12.776.124.486.485.114.224.060.798 Ipilimumab 253
D12.776.124.486.485.114.224.060.813 Natalizumab 156
D12.776.124.486.485.114.224.060.829 Nivolumab 427
D12.776.124.486.485.114.224.060.844 Omalizumab 112
D12.776.124.486.485.114.224.060.860 Palivizumab 12
D12.776.124.486.485.114.224.060.864 Panitumumab 57
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 61
D12.776.124.486.485.114.224.060.875 Trastuzumab 268
D12.776.124.486.485.114.224.060.937 Ustekinumab 120
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 486
D12.776.124.790.651.114 Antibodies 1 815
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 626
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 783
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 346
D12.776.124.790.651.114.224.060.375 Alemtuzumab 123
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 445
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 40
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 47
D12.776.124.790.651.114.224.060.750 Cetuximab 185
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 150
D12.776.124.790.651.114.224.060.790 Gemtuzumab 16
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 11
D12.776.124.790.651.114.224.060.798 Ipilimumab 253
D12.776.124.790.651.114.224.060.813 Natalizumab 156
D12.776.124.790.651.114.224.060.829 Nivolumab 427
D12.776.124.790.651.114.224.060.844 Omalizumab 112
D12.776.124.790.651.114.224.060.860 Palivizumab 12
D12.776.124.790.651.114.224.060.864 Panitumumab 57
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 61
D12.776.124.790.651.114.224.060.875 Trastuzumab 268
D12.776.124.790.651.114.224.060.937 Ustekinumab 120
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 486
D12.776.377.715.548.114 Antibodies 1 815
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 626
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 783
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 346
D12.776.377.715.548.114.224.200.375 Alemtuzumab 123
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 445
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 40
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 47
D12.776.377.715.548.114.224.200.750 Cetuximab 185
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 150
D12.776.377.715.548.114.224.200.790 Gemtuzumab 16
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 11
D12.776.377.715.548.114.224.200.798 Ipilimumab 253
D12.776.377.715.548.114.224.200.813 Natalizumab 156
D12.776.377.715.548.114.224.200.829 Nivolumab 427
D12.776.377.715.548.114.224.200.844 Omalizumab 112
D12.776.377.715.548.114.224.200.860 Palivizumab 12
D12.776.377.715.548.114.224.200.864 Panitumumab 57
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 61
D12.776.377.715.548.114.224.200.875 Trastuzumab 268
D12.776.377.715.548.114.224.200.937 Ustekinumab 120